Literature DB >> 18283529

The hemostatic balance revisited through the lessons of mankind evolution.

Massimo Franchini1, Pier Mannuccio Mannucci.   

Abstract

Under physiologic conditions, a hemostatic balance is achieved through the effects of natural procoagulant and anticoagulant factors which, in equilibrium with each other, provide hemostasis at the sites of vascular injury. Abnormalities of these hemostasis factors can result in a tendency toward hemorrhagic or thrombotic events. In this review the influence of inherited prothrombotic risk factors--especially the more frequent factor V Leiden and prothrombin gene mutations--on normal and abnormal hemostasis is analyzed from an evolutionary point of view. The effect of inherited bleeding disorders on the development of thrombotic or atherosclerotic processes is also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283529     DOI: 10.1007/s11739-008-0100-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  48 in total

1.  Cardiovascular protection in haemophilia.

Authors:  Stefan Kiechl; Johann Willeit
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

2.  Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants.

Authors:  Christoph Härtel; Inke König; Stefan Köster; Evelyn Kattner; Eckhardt Kuhls; Helmut Küster; Jens Möller; Dirk Müller; Angela Kribs; Hugo Segerer; Christian Wieg; Egbert Herting; Wolfgang Göpel
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

Review 3.  Inherited thrombophilia: Part 1.

Authors:  D A Lane; P M Mannucci; K A Bauer; R M Bertina; N P Bochkov; V Boulyjenkov; M Chandy; B Dahlbäck; E K Ginter; J P Miletich; F R Rosendaal; U Seligsohn
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

4.  Human genetics. Bad blood by mutation.

Authors:  P W Majerus
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

Review 5.  Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

Authors:  V De Stefano; G Finazzi; P M Mannucci
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

6.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

7.  Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.

Authors:  A Srámek; P Bucciarelli; A B Federici; P M Mannucci; V De Rosa; G Castaman; M Morfini; M G Mazzucconi; A Rocino; M Schiavoni; F A Scaraggi; J H C Reiber; F R Rosendaal
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

Review 8.  Thrombotic complications in patients with hereditary bleeding disorders.

Authors:  Massimo Franchini
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

9.  Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.

Authors:  A A Arbini; P M Mannucci; K A Bauer
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

10.  Decreased mortality of ischaemic heart disease among carriers of haemophilia.

Authors:  A Srámek; M Kriek; F R Rosendaal
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

View more
  3 in total

1.  Human genome, environment and medical practice.

Authors:  Giovanni Di Minno; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2013-11-07       Impact factor: 3.397

2.  Mankind adaptation and present human health.

Authors:  Franco Contaldo; Salvatore Auricchio
Journal:  Intern Emerg Med       Date:  2008-06-25       Impact factor: 3.397

3.  Human genome, environment and medical practice.

Authors:  Sergio Coccheri
Journal:  Intern Emerg Med       Date:  2014-05-21       Impact factor: 3.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.